| Medicare WPS | Billing and Coding: Somatosensory Testing (57597) | 2025-09-16 |
| Medicare WPS | Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound (59434) | 2025-09-16 |
| BCBS Texas Medical Policies | Ocrelizumab or Ocrelizumab and Hyaluronidase-ocsq | 2025-09-15 |
| BCBS Oklahoma Medical Policies | Ocrelizumab or Ocrelizumab and Hyaluronidase-ocsq | 2025-09-15 |
| BCBS New Mexico Medical Policies | Ocrelizumab or Ocrelizumab and Hyaluronidase-ocsq | 2025-09-15 |
| BCBS Montana Medical Policies | Ocrelizumab or Ocrelizumab and Hyaluronidase-ocsq | 2025-09-15 |
| BCBS Florida Coverage Guidelines | Blood Glucose Monitors and Supplies (09-E0000-14) | 2025-09-15 |
| BCBS Florida Coverage Guidelines | Brentuximab (Adcetris®) Injection (09-J1000-53) | 2025-09-15 |
| BCBS Florida Coverage Guidelines | Bronchial Thermoplasty (02-30000-12) | 2025-09-15 |
| BCBS Florida Coverage Guidelines | Carfilzomib (Kyprolis®) Injection (09-J1000-81) | 2025-09-15 |